8:05am ET
Investing
Cramer’s Stock Picks at the Market Top
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Companies
/Healthcare
Mannkind Corp
$4.09
▼ $0.01 (−0.12%) today
Markets open · 4:13pm ET
Today · % change
Fundamentals
Market Cap
$1.3B
Profit Margin
-11.1%
Revenue (TTM)
$393.6M
EPS (TTM)
$-0.15
52-Week Range
$2 – $7
Street Target
$7.97
About MannKind
MannKind Corporation is a pioneering biopharmaceutical firm dedicated to creating inhaled therapeutic products for diabetes and rare lung diseases. Its flagship product, Afrezza, is an innovative inhaled insulin offering a new approach to glycemic control in adults. Additionally, MannKind is developing treatments for pulmonary arterial hypertension and other serious lung conditions. With strategic partnerships for global distribution and a commitment to advancing respiratory health, MannKind stands at the forefront of inhalation technology for medical treatments.
MNKD Coverage
8:25am ET
Health and Healthcare
Short Sellers Shy Away From Big Biotech
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
9:41am ET
Health and Healthcare
Big Biotechs Scare Off Short Sellers
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
9:43am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Biotechs
The June 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
9:46am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
10:01am ET
Health and Healthcare
Major Biotechs Have Short Sellers on the Run
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
9:37am ET
Health and Healthcare
Major Biotechs See More Targeted Short Sellers
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
9:36am ET
Health and Healthcare
Short Sellers Raise the Stakes in Major Biotechs
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
8:47am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
9:40am ET
Health and Healthcare
Big Biotechs Scare Off Short Sellers
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
9:45am ET
Health and Healthcare
Major Biotechs Get Mixed Message on Short Interest
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
9:13am ET
Health and Healthcare
Big Biotechs Have Short Sellers Confused
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
8:35am ET
Health and Healthcare
Major Biotechs Have Short Sellers Confused
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
8:45am ET
Health and Healthcare
Biotech Short Sellers Focus on a Couple Favorites
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
8:45am ET
Health and Healthcare
Short Sellers Wary on Major Biotechs
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.